Financhill
Back

Neurocrine Biosciences, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
64

NBIX
Neurocrine Biosciences, Inc.

Last Price:
$144.97
Seasonality Move:
8.49%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Neurocrine Biosciences, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 149.32 Sell
20-day SMA: 150 Sell
50-day SMA: 145.87 Sell
200-day SMA: 129.69 Buy
8-day EMA: 147.57 Sell
20-day EMA: 148.72 Sell
50-day EMA: 146.3 Sell
200-day EMA: 136.1 Buy

Neurocrine Biosciences, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.16 Buy
Relative Strength Index (14 RSI): 44.3 Sell
Chaikin Money Flow: 1222295 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (142.1 - 154.22) Sell
Bollinger Bands (100): (134.03 - 149.03) Buy

Neurocrine Biosciences, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Neurocrine Biosciences, Inc. Stock

Is Neurocrine Biosciences, Inc. Stock a Buy?

NBIX Technical Analysis vs Fundamental Analysis

Buy
64
Neurocrine Biosciences, Inc. (NBIX) is a Buy

Is Neurocrine Biosciences, Inc. a Buy or a Sell?

Neurocrine Biosciences, Inc. Stock Info

Market Cap:
14.5B
Price in USD:
145.00
Share Volume:
2M

Neurocrine Biosciences, Inc. 52-Week Range

52-Week High:
160.18
52-Week Low:
84.23
Buy
64
Neurocrine Biosciences, Inc. (NBIX) is a Buy

Neurocrine Biosciences, Inc. Share Price Forecast

Is Neurocrine Biosciences, Inc. Stock a Buy?

Fundamental Analysis of Neurocrine Biosciences, Inc.

Is Neurocrine Biosciences, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and an increase next year of $2.30 per share.

Technical Analysis of Neurocrine Biosciences, Inc.

Should I short Neurocrine Biosciences, Inc. stock?

* Neurocrine Biosciences, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.